Filter This View

  • July 31, 2006 | New Jersey Law Journal

    Pharmaceutical Companies Use Compliance Counsel for Relief From 'Off-Label' Inquiries

    Compliance counsel for pharmaceutical companies are becoming more involved in "off-label" promotion and marketing issues than in the past. Compliance counsel -- both inside the corporation and

    1 minute read

  • September 20, 2007 | New Jersey Law Journal

    Attorney Ineligibility Order Pursuant to Rule 1:28-2(a)

    Pursuant to Rule 1:28-2, the Trustees of the New Jersey Lawyers' Fund for Client Protection have reported to the Supreme Court the names of those attorneys who have neither made full payment t

    1 minute read

  • April 19, 2005 | New York Law Journal

    Antitrust Trade and Practice

    On March 8, 2005, the U.S. Court of Appeals for the Eleventh Circuit, in Schering-Plough Corp. v. Federal Trade Commission, held that "reverse payments" included in patent infringement

    1 minute read

  • October 19, 2010 | New Jersey Law Journal

    In-House at Large Public Companies

    table cols="5" xmlns:saxon="http://saxon.sf.net/" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:k4="http://www.vjoon.com/K4Export/1.4.2" xmlns:ma

    1 minute read

  • In re Novartis Wage and Hour Litigation, 09-0437-cv

    Publication Date: 2010-07-08
    Practice Area:
    Industry:
    Court: Court of Appeals, Second Circuit
    Judge: Before: Kearse and Hall, C.JJ., Rakoff, D.J.*
    Attorneys: For plaintiff: Jeremy Heisler, New York, New York (David W. Sanford, Katherine M. Kimpel, Sanford, Wittels & Heisler, Washington, D.C., Steven Wittels, Andrew Melzer, Sanford, Wittels & Heisler, New York, New York, on the brief), for Plaintiffs-Appellants. Jennifer R. Marion, United States Department of Labor, Washington, D.C. (Carol A. De Deo, Deputy Solicitor for National Operations, William C. Lesser, Deputy Associate Solicitor, Paul L. Frieden, Counsel for Appellate Litigation, United States Department of Labor, Washington, D.C., on the brief), for Amicus Curiae Secretary of Labor in support of Plaintiffs-Appellants. Outten & Golden, New York, New York (Justin M. Swartz, Rachel Bien, Outten & Golden, New York, New York, Catherine K. Ruckelshaus, National Employment Law Project, New York, New York, George A. Hanson, Bradley T. Wilders, Stueve Siegel Hanson, Kansas City, Missouri, Rebecca M. Hamburg, National Employment Lawyers Association, San Francisco, California, Richard J. (Rex) Burch, Bruckner Burch, Houston, Texas, of counsel), filed a brief on behalf of Amicus Curiae National Employment Lawyers Association in support of Plaintiffs-Appellants.
    for defendant: Richard H. Schnadig, Chicago, Illinois (Vedder Price, Chicago, Illinois, Jonathan A. Wexler, Vedder Price, New York, New York, on the brief), for Defendant-Appellee. Paul, Hastings, Janofsky & Walker, Washington, D.C. (Neal D. Mollen, Paul, Hastings, Janofsky & Walker, Washington, D.C., Robin S. Conrad, Shane B. Kawka, National Chamber Litigation Center, Washington, D.C., of counsel), filed a brief on behalf of Amicus Curiae Chamber of Commerce of the United States of America in support of Defendant-Appellee.
    Case Number: 09-0437-cv

    Before: Kearse and Hall, C.JJ., Rakoff, D.J.*Decided: July 06, 2010Jeremy Heisler, New York, New York (David W. Sanford, Kathe

  • November 15, 2004 | New Jersey Law Journal

    Aventis Pharmaceuticals Inc. et al v. Barr Laboratories Inc. et al

    U.S. District Court No. 02-1322; United States District Court (DNJ); opinion by Greenaway, U.S.D.J.; filed October 22, 2004. DDS No. 53-7-8165 This is a patent infringe

    1 minute read

  • August 24, 2010 | The Legal Intelligencer

    Analysis: Pfizer Appeals Court's Recognition of New Pharma Cause of Action

    In the wake of the Pennsylvania Superior Court's recognition of a new pharmaceutical liability cause of action, drugmaker Pfizer is asking the appeals court to reconsider or hold a new en banc argu

    1 minute read

  • September 13, 2002 | The American Lawyer

    Patently Political

    It was the morning of July 2 -- the short, slow workweek preceding the Independence Day holiday. Christine White, a health care antitrust partner at Chicago's McDermott, Will & Emery, was

    1 minute read

  • July 31, 2006 | New Jersey Law Journal

    Pharmaceutical Companies Use Compliance Counsel for Relief From 'Off-Label' Inquiries

    Compliance counsel for pharmaceutical companies are becoming more involved in "off-label" promotion and marketing issues than in the past. Compliance counsel -- both inside the corporation and

    1 minute read

  • February 15, 2012 | Delaware Business Court Insider

    Chancery Court Limits CEO's Right to Indemnification After Regulatory Row

    The court held that the executive's decision to accept lesser charges in order to spare the company "expense [and] distraction" does not satisfy the "successful on the

    1 minute read